Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Thermo Fisher Scientific Strategic Investments

Profile and portfolio

Parent Thermo Fisher ScientificHQ Waltham, United States

Thermo Fisher Scientific Strategic Investments is the corporate venture arm of Thermo Fisher Scientific, a healthcare company. It is based in Waltham, United States. It invests at the Series C+ stage. Sectors it names: biotech and life sciences, artificial intelligence.

Every figure links to its source

Snapshot

Investment stage: Series C+ to Series C+
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeries C+ to Series C+
SectorsBiotech and life sciences, Artificial intelligence
GeographyNorth America, Europe, Middle East and Africa
OfficesWaltham, United States

Sources: S2 miDiagnostics: EUR 30m Series D led by Thermo Fisher Scientific.

Graphic 1 of 1

Investment stage: Series C+ to Series C+

Sources: S2 miDiagnostics: EUR 30m Series D led by Thermo Fisher Scientific.

Download:Report a correction

Where it invests

Geography

Headquarters
Waltham, United States
Offices
  • Waltham, United States

Investment regionsS2

Key facts

FactValueStatusSource
Parent companyThermo Fisher Scientific (NYSE: TMO)Single sourceS1
Parent industryHealthcare and life sciencesSingle sourceS1
HeadquartersWaltham, United StatesSingle sourceS1
StatusActiveSingle sourceS1
Capital sourceParent company onlySingle sourceS2
StagesSeries C+ (inferred from announced rounds)EstimateS2

About Thermo Fisher Scientific

ItemDetailSource
Listed asNYSE: TMOS1
HeadquartersUnited StatesS1

Recent rounds

DateCompanyRoundAmountLed by the firmSource
2024-12-04miDiagnosticsSeries C+EUR 30MYesS2
2024-07-17CytoReasonNot statedUSD 80MNoS3
2022-05-11IonpathNot statedNot statedS4

Portfolio

Public sources name 3 portfolio companies.S2

Every company on the Thermo Fisher Scientific Strategic Investments list

3 companies, as named in the sources cited.S2 Read the firm's list.

  • CytoReason
  • Ionpath
  • miDiagnostics

Official pages

Read the firm's own pages for current information.

Sources

  1. S1SEC EDGAR: Thermo Fisher Scientific (NYSE: TMO, business address Waltham MA)Filing
  2. S2miDiagnostics: EUR 30m Series D led by Thermo Fisher ScientificPortfolio company
  3. S3Business Wire: CytoReason secures USD 80m from OurCrowd, NVIDIA, Pfizer and Thermo Fisher ScientificPortfolio company
  4. S4Business Wire: Ionpath receives strategic investment (Thermo Fisher Scientific)Portfolio company

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Thermo Fisher Scientific Strategic Investments or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.